EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The Impact of Non-bone Metastatic Cancer on Musculoskeletal Health

Fabiola Galiana-Melendez, Joshua R Huot

Current Osteoporosis Reports · 2024-06 · 22 (3) · 318-329

DOI: 10.1007/s11914-024-00872-4 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Osteoporosis Reports, online erschienen am 22.04.2024. Verfasst von Fabiola Galiana-Melendez und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy, Cell Biology & Physiology, Indianapolis, IN, 46202, USA. Hauptthemen laut MEDLINE: Cachexia, Muscle, Skeletal, Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 144 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE OF REVIEW: The purpose of this review is to discuss the musculoskeletal consequences of cancer, including those that occur in the absence of bone metastases. RECENT FINDINGS: Cancer patients frequently develop cachexia, a debilitating condition reflected by weight loss and skeletal muscle wasting. The negative effects that tumors exert on bone health represents a growing interest amongst cachexia researchers. Recent clinical and pre-clinical evidence demonstrates cancer-induced bone loss, even in the absence of skeletal metastases. Together with muscle wasting, losses in bone demonstrates the impact of cancer on the musculoskeletal system. Identifying therapeutic targets that comprehensively protect musculoskeletal health is essential to improve the quality of life in cancer patients and survivors. IL-6, RANKL, PTHrP, sclerostin, and TGF-β superfamily members represent potential targets to counteract cachexia. However, more research is needed to determine the efficacy of these targets in protecting both skeletal muscle and bone.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CachexiaMuscle, SkeletalNeoplasmsHumansParathyroid Hormone-Related ProteinRANK LigandInterleukin-6Transforming Growth Factor betaQuality of LifeAdaptor Proteins, Signal TransducingBone Morphogenetic Proteins

Stichwörter der Autor:innen

Cancer cachexiaMusculoskeletal healthNon-bone cancerSkeletal muscle

Substanzen

Parathyroid Hormone-Related ProteinRANK LigandSOST protein, humanInterleukin-6Transforming Growth Factor betaAdaptor Proteins, Signal TransducingBone Morphogenetic ProteinsTNFSF11 protein, human

Autor:innen und Institutionen

  • Department of Anatomy, Cell Biology & Physiology, Indianapolis, IN, 46202, USA.
  • Department of Anatomy, Cell Biology & Physiology, Indianapolis, IN, 46202, USA. jrhuot@iu.edu.
  • Indiana Center for Musculoskeletal Health, Indianapolis, IN, USA. jrhuot@iu.edu.
  • Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN, USA. jrhuot@iu.edu.
  • Department of Kinesiology, School of Health and Human Sciences, Indiana University Purdue University Indianapolis, Indianapolis, IN, USA. jrhuot@iu.edu.

Zitieren

APA

Galiana-Melendez, F., & Huot, J. R. (2024). The Impact of Non-bone Metastatic Cancer on Musculoskeletal Health. Current Osteoporosis Reports, 22(3), 318-329. https://doi.org/10.1007/s11914-024-00872-4

Vancouver

Galiana-Melendez F, Huot JR. The Impact of Non-bone Metastatic Cancer on Musculoskeletal Health. Current Osteoporosis Reports. 2024;22(3):318-329. doi:10.1007/s11914-024-00872-4

BibTeX
@article{GalianaMelendez2024,
  author = {Galiana-Melendez, Fabiola and Huot, Joshua R},
  title = {The Impact of Non-bone Metastatic Cancer on Musculoskeletal Health},
  journal = {Current Osteoporosis Reports},
  year = {2024},
  volume = {22},
  number = {3},
  pages = {318--329},
  doi = {10.1007/s11914-024-00872-4}
}
Kostenlos starten →